trending Market Intelligence /marketintelligence/en/news-insights/trending/krm1lzumplqtzgtu1o6n7q2 content esgSubNav
In This List

Marinus adds former Pacira Pharmaceuticals COO to board

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Marinus adds former Pacira Pharmaceuticals COO to board

Marinus Pharmaceuticals Inc. appointed Scott Braunstein to its board.

Braunstein currently serves as an operating partner at Aisling Capital Management LP, a New York-based venture capital and private equity firm.

Prior to joining Aisling, Braunstein was the COO of Pacira Pharmaceuticals Inc., a Parsippany, N.J.-based specialty pharmaceutical company that develops and manufactures products for acute care practitioners and their patients.

Radnor, Pa.-based Marinus Pharmaceuticals is focused on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders.